Delta Financial Group, Inc.
- SEC CIK
- 0001965718
- Latest filing
- May 9, 2025
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by Delta Financial Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q1 2025 holdings
- Shares (Q1 2025)
- 509
- Value
- $336.0K
- % of portfolio
- 0.1%
- Quarters held
- 10
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 509 | $336.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 509 | $363.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 509 | $535.0K | 0.2% | −50−8.9% | Reduced | Holders |
| Q2 2024 | 559 | $588.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 559 | $538.0K | 0.2% | −100−15.2% | Reduced | Holders |
| Q4 2023 | 659 | $579.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 659 | $542.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2023 | 659 | $474.0K | 0.6% | −201−23.4% | Reduced | Holders |
| Q1 2023 | 860 | $707.0K | 0.3% | +1+0.1% | Added | Holders |
| Q4 2022 | 859 | $611.0K | 0.3% | – | No prior filing | Holders |